The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined PD-1 inhibition (Pembrolizumab) and CCR5 inhibition (Maraviroc) for the treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): First results of the PICCASSO phase I trial.
 
Georg Martin Haag
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); EsoCap Biotech; MSD Oncology (Inst)
Speakers' Bureau - SERVIER
Research Funding - MSD Oncology (Inst); Nordic Group (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (Inst); Lilly (Inst)
 
Niels Halama
No Relationships to Disclose
 
Christoph Springfeld
Consulting or Advisory Role - Celgene; Eisai; MSD; MSD; Roche; SERVIER; SERVIER
Travel, Accommodations, Expenses - Celgene; Servier
 
Barbara Grün
No Relationships to Disclose
 
Leonidas Apostolidis
Honoraria - Eisai; Ipsen; Novartis
Consulting or Advisory Role - SERVIER
Research Funding - Ipsen (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Stefanie Zschaebitz
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Eisai; Merck Serono; MSD; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Astellas Oncology; EUSA Pharma; Ipsen
 
Mareike Dietrich
Consulting or Advisory Role - SERVIER
 
Anne-Katrin Berger
No Relationships to Disclose
 
Tim Frederik Weber
Consulting or Advisory Role - Bayer
 
Inka Zoernig
No Relationships to Disclose
 
Lisa Waberer
No Relationships to Disclose
 
Daniel Wilhelm Mueller
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - IKF Klinische Krebsforschung
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Nordic Bioscience; Roche
Speakers' Bureau - AIO gGmbH; Celgene; Forum für Medizinische Fortbildung; Lilly; MCI group; Nordic Bioscience
Research Funding - Celgene; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Lilly; Medac; Merck; Roche; Sanofi; Vifor Pharma
 
Dirk Jaeger
Consulting or Advisory Role - Amgen (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)